Sara Rogers, PharmD, BCPT, is the Cofounder and Director of Clinical Affairs at the American Society of Pharmacovigilance (ASP), an organization with the goal to rapidly and dramatically reduce the high rate of adverse drug events (ADEs) in the US. She co-chairs the Pharmacogenomics Access and Reimbursement Coalition (PARC) to address pain issues and the barriers posed for widespread implementation of pharmacogenetic testing, a proven tool for proactively addressing medication side effects. Sara also co-developed the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) initiative, a public and private multidisciplinary collaborative community to accelerate the development of personalized medicine practices as a standard of care.
Leveraging a precision prescribing platform with embedded genomic analysis will help physicians improve care and reduce costs by providing valuable information to inform mental health medication choices that can deliver treatment success for their patients from the start.